# Irbesartan and Hydrochlorothiazide

NDC: 65862-629
Generic name: Irbesartan and Hydrochlorothiazide
Labeler / Manufacturer: Aurobindo Pharma Limited
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, FILM COATED
Routes: ORAL
Marketing started: 20130222

FDA application: ANDA203630

## Active ingredients

- HYDROCHLOROTHIAZIDE: 12.5 mg/1
- IRBESARTAN: 150 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"65862-629"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=65862-629
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=466dd0d2-9815-4c3e-b66b-d0732b3ba8e9